Adjuvant Chemotherapy In Gastric Cancer Quito-Ecuador

OBJECTIVE:To determine the overall survival time in patients treated with adjuvant chemoradiotherapy.METHODS:Retrospectivestudyofpatientswithadiagnosisofgastricadenocarcinomaor gastroesophageal junction who received adjuvant chemoradiotherapy treatment during the years 2011 to 2015.RESULTS:We analized 197 subjects of which 115 were men (58.4%) and 82 women (41.6%) were included in the analysis; between the ages of 18 and 89 years old, distributed in clinical stages IB to IIIC, showing a general average survival of 51.5 months with a Log Rank of 2.98; 95% CI (45.7 - 57.4) with a general survival of up to 90 months.CONCLUSION:The study showed a greater overall survival than the data reported in the Intergroup 0116 and ARTIST study.